Vital Care Express

library_booksAll News

Page 1 of 7

search

A diabetes and weight-loss drug was tied to nearly 40 percent fewer asthma attacks, and it was one drug in the class, not all of them

A large real-world study of UK health records linked semaglutide, the ingredient in Ozempic and Wegovy, to far fewer asthma attacks and COPD flare-ups, but the benefit did not show up for the other GLP-1 drugs tested

An AI-Designed Lung Drug Made Patients' Blood Look Years Younger. Six Aging Clocks Agreed

Rentosertib Shifted Six Proteomic Aging Clocks Toward a Younger Age in a Lung Fibrosis Trial

Modified Ketogenic Diet Reduces Autism Symptoms in Randomized Pediatric Trial

Modified Ketogenic Diet Shows Promise for Pediatric Autism Symptoms

Oral Deucrictibant Cut Hereditary Angioedema Attacks by 83 Percent in Phase 3 Trial

Oral Deucrictibant Cuts Hereditary Angioedema Attacks 83 Percent

Vosoritide Increases Growth Rate in Phase 3 Hypochondroplasia Study

Phase 3 Trial Shows Vosoritide Accelerates Growth in Hypochondroplasia

Phase 2 Mosliciguat Trial Yields 56.3 Percent PVR Reduction in PH-ILD, Phase 3 PHrontier Begins

Mosliciguat Shows 56.3 Percent PVR Cut in Phase 2 PH-ILD Study

Novo Nordisk STEP Young Trial Shows 40.4% of Children Moved Below Obesity Threshold

Semaglutide Helps 40.4% of Pediatric Trial Group Fall Below Obesity Cutoff

Israeli Researchers Develop $60 Blood Test Detecting Stage 2-4 Lung Cancer with 93% Accuracy

Israeli Researchers Develop $60 Blood Test for Stage 2-4 Lung Cancer

Genetics of Personality Tied to Major Life Outcomes in 46-Cohort Global Study

Genetics of Personality Tied to Major Life Outcomes in Global Study

A once-daily pill cut MS relapses in two big trials, but Novartis is holding the exact numbers back

Novartis says its oral BTK inhibitor remibrutinib beat a standard MS pill on relapses and showed no liver safety signal in the Phase III REMODEL trials, with full data still to come

Microplastics in Human Lungs: Higher Burden Found in Lung Cancer Patients

Study Links Higher Microplastic Burden to Lung Cancer Patients

First Antibody Drug for Active Dengue Clears Virus Faster in Early Trial

A Single Antibody Infusion Cleared Dengue Virus and Fever Faster in a Phase 2 Trial, But the Study Was Too Small to Prove It Works